Findings from Brigham and Women's Hospital Update Knowledge of Carcinomas (Cabozantinib Plus Nivolumab and Ipilimumab In Renal-cell Carcinoma)

Press/Media

Period22 Aug 2023

Media coverage

1

Media coverage